Germany
Japan
United Kingdom
China
Antibodies
View as table Download
USD 500.00
5 Days
USD 500.00
5 Days
Rat Monoclonal TLR4 Antibody (MTS510)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
TA336405 is a possible alternative to AM26522FC-N.
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
| Applications | ELISA, FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD3 epsilon (Clone OKT-3 (muromonab))
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD20 (Clone 10F381 (rituximab))
| Applications | FC |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-EGFR (Clone 528)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-VAP-1 (Clone TK8-14)
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD8 alpha (Clone YTS 105.18)
| Applications | FC, IF, IHC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD29 (Clone K20)
| Applications | FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-Flavivirus group antigen (Clone D1-4G2-4-15 (4G2))
| Applications | ELISA, FC, IF, IHC, WB |
| Reactivities | Dengue virus, West Nile Virus, Yellow Fever Virus |
| Conjugation | Unconjugated |
Recombinant Anti-CD37 (Clone WR17)
| Applications | FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD35 (complement receptor 1) (Clone 8C12)
| Applications | FC, IHC, IP, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-Polysialic acid (Clone 735)
| Applications | FC, IHC, IP |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Ly6G (Clone 1A8)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-PDL1 (Clone YDC 127.1.1)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))
| Applications | FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Interleukin 7 Receptor (Clone YIL7R323)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD11a (Clone hu1124 (Efalizumab))
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD19 (Clone FMC63)
| Applications | FC, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD62L (Clone MEL-14)
| Applications | FC, IHC, IP |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD105 (Clone MJ7/18)
| Applications | FC, IHC, IP, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-Integrin beta-7 (Clone FIB504)
| Applications | FC, IF |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-Integrin beta-7 (Clone FIB27)
| Applications | FC, IP |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD44 (Clone Hermes-1)
| Applications | Bl, ELISA, FC, IF, IHC, IP, Neutralize, WB |
| Reactivities | Bovine, Goat, Human, Mouse, Primate, Rabbit, Rat, Sheep |
| Conjugation | Unconjugated |
Recombinant Anti-CD3 epsilon (Clone 12F6)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-VEGF (Clone Bevacizumab)
| Applications | ELISA, FC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-EGFR domain III (Clone h-R3 (Nimotuzumab))
| Applications | FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD154 (Clone YMF323.6)
| Applications | FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-PD-1 (Clone RMP1-14)
| Applications | FC, IHC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-4-1BBL (Clone TKS-1)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-ICOSL (Clone HK5.3)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-PD-L2 (Clone TY25)
| Applications | FC, IP, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD27 (Clone RM27-3E5)
| Applications | FC, IP, Neutralize |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD8 (Clone G10-1)
| Applications | FC, IF, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD3e (Clone 898H2-6-15)
| Applications | FC, IHC |
| Reactivities | Pig |
| Conjugation | Unconjugated |
Recombinant Anti-CD205 (Clone NLDC145)
| Applications | FC, IF, IHC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Active filters
Applications
- FC
Isotypes
- IgG2a, kappa
Filter by
Category
Target Symbol
- CD3E (3)
- EBI3 (3)
- CCRL2 (2)
- CD40 (2)
- CD40LG (2)
- EGFR (2)
- ITGB7 (2)
- LAG3 (2)
- LY6G (2)
- TLR2 (2)
- AOC3 (1)
- BIRC5 (1)
- C5AR1 (1)
- CCR5 (1)
- CCR7 (1)
- CCR9 (1)
- CD19 (1)
- CD27 (1)
- CD274 (1)
- CD33 (1)
- CD37 (1)
- CD4 (1)
- CD44 (1)
- CD53 (1)
- CD70 (1)
- CD8 (1)
- CD80 (1)
- CD8A (1)
- CMKLR1 (1)
- CR1 (1)
- CSF1R (1)
- ENG (1)
- EPCAM (1)
- ERBB2 (1)
- GROUP ANTIGEN (1)
- HAVCR1 (1)
- HSPA4 (1)
- ICOSL (1)
- IFNGR1 (1)
- IGF2R (1)
- IL16 (1)
- IL2RB (1)
- IL3RA (1)
- IL7R (1)
- ITGA2B (1)
- ITGAL (1)
- ITGB1 (1)
- ITGB2 (1)
- LGALS9 (1)
- LY75 (1)
- MS4A1 (1)
- MYC (1)
- PDCD1 (1)
- PDCD1LG2 (1)
- PECAM1 (1)
- POLYSIALIC ACID (1)
- PTPRC (1)
- PVR (1)
- SELL (1)
- SLC3A2 (1)
- TFRC (1)
- TLR4 (1)
- TLR5 (1)
- TNF (1)
- TNFRSF9 (1)
- TNFSF11 (1)
- TNFSF15 (1)
- TNFSF9 (1)
- TYRP1 (1)
- VEGFA (1)
Reactivities
Antibody Hosts
Clonalities
Conjugates
Modifications
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (8)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (11)
- Transmembrane (7)
- Secreted Protein (3)
- ES Cell Differentiation/IPS (2)
- Stem cell - Pluripotency (2)
- Embryonic stem cells (1)
- Induced pluripotent stem cells (1)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
- Stem cell relevant signaling - Wnt Signaling pathway (1)
- Transcription Factors (1)
Pathways
- Toll-like receptor signaling pathway (3)
- Colorectal cancer (2)
- Pathogenic Escherichia coli infection (2)
- Pathways in cancer (2)
- Acute myeloid leukemia (1)
- Antigen processing and presentation (1)
- Bladder cancer (1)
- Cell adhesion molecules (CAMs) (1)
- Cell cycle (1)
- Chronic myeloid leukemia (1)
- Endometrial cancer (1)
- ErbB signaling pathway (1)
- Jak-STAT signaling pathway (1)
- Leukocyte transendothelial migration (1)
- Lysosome (1)
- MAPK signaling pathway (1)
- Small cell lung cancer (1)
- TGF-beta signaling pathway (1)
- Thyroid cancer (1)
- Wnt signaling pathway (1)